Therapeutic Category
Anti-infective
FLUCLOPEN
Targeted therapy against MSSA bacteria.
Anti-infective Brand
FLUCLOPEN
FLUCLOPEN is used in the treatment of susceptible bacterial infections caused by MSSA bacteria. It is available in Capsules, Oral suspensions, and Injectable formulations.
Dosage form
Capsules, Oral Suspension and Injection
Strengths Available
500mg Capsules, 250mg/ml Suspension, 1gm Injection
Pack sizes
Pack of 2X10 Capsules,100mL Bottle, 1 Vial for Injection
Therapeutic Indications
- Respiratory tract infections: pneumonia, lung abscess, empyema, Sinusitis , Pharyngitis, Tonsillitis and tonsillar abscess
- Ear infections: Otitis Media and Externa
- Urinary tract infections
- Bones: Osteomyelitis
Brand Name
FLUCLOPEN
Product Name
FLUCLOPEN 500
Generic Name
Flucloxacillin Capsules BP 500mg
Dosage Form
Capsules
Pack Size
Pack of 2x10 Capsules
Therapeutic Indication
Indicated for the treatment of bacterial infections affecting the skin and soft tissues, respiratory tract, bones, and urinary tract.
Dosage and Method of Administration
Adults and children over 12 years: Usually 1–3 g daily.
The usual dose is 1 capsule every 6–8 hours
Mode of Administration
For oral use only
Brand Name
FLUCLOPEN
Product Name
FLUCLOPEN 250
Generic Name
Flucloxacillin Oral Solution BP 250mg/5ml
Dosage Form
Oral Solution
Pack Size
Pack of 100mL Bottle
Therapeutic Indication
Indicated for the treatment of bacterial infections affecting the skin and soft tissues, respiratory tract, bones, and urinary tract.
Dosage and Method of Administration
Adults and children over 12 years: 5 mL every 6–8 hours
Children 2–10 years: 5 mL three times daily
Children under 2 years: 2.5 mL three times daily
Mode of Administration
For oral use only.
Brand Name
FLUCLOPEN
Product Name
FLUCLOPEN 1000
Generic Name
Flucloxacillin Injection BP 1000mg
Dosage Form
Injection
Pack Size
1 vial + 10mL Injection
Therapeutic Indication
Indicated for the treatment of bacterial infections affecting the skin and soft tissues, respiratory tract, bones, and urinary tract.
Dosage and Method of Administration
Adults and children over 14 years: 1–3 g daily, divided into 4 doses.
Severe infections: Up to 8 g daily, divided into 4 infusions, each given over 20–30 minutes. Maximum 2 g per infusion.
Children under 14 years: 25–50 mg/kg/day, divided into 3–4 doses.
Severe infections in children: Up to 100 mg/kg/day, divided into 3–4 doses. Maximum 33 mg/kg per dose.
Mode of Administration
For I.V use only.